{{Rsnum
|rsid=6964705
|Gene=EGFR
|Chromosome=7
|position=55141944
|Orientation=plus
|GMAF=0.4568
|Gene_s=EGFR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 24.3 | 46.8 | 28.8
| HCB | 35.6 | 51.5 | 12.9
| JPT | 45.5 | 46.4 | 8.0
| YRI | 4.2 | 34.0 | 61.8
| ASW | 8.8 | 42.1 | 49.1
| CHB | 35.6 | 51.5 | 12.9
| CHD | 36.8 | 55.7 | 7.5
| GIH | 12.9 | 53.5 | 33.7
| LWK | 3.7 | 25.2 | 71.0
| MEX | 24.1 | 46.6 | 29.3
| MKK | 5.2 | 38.1 | 56.8
| TSI | 16.7 | 54.9 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23593148
|Title=SNP-SNP Interaction Network in Angiogenesis Genes Associated with Prostate Cancer Aggressiveness
|OA=1
}}

{{PMID Auto
|PMID=19190167
|Title=A two-stage case-control study of EGFR polymorphisms and breast cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}